CB2 Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?Amey Dhopeshwarkar, Ken Mackie|Molecular Pharmacology|2014Cited by 257
Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 AntagonistsAmey Dhopeshwarkar, Ken Mackie|Journal of Pharmacology and Experimental Therapeutics|2016Cited by 26